Your browser doesn't support javascript.
loading
A Double-Blind, Randomized, Placebo-Controlled, Phase II Clinical Study To Evaluate the Efficacy and Safety of Camostat Mesylate (DWJ1248) in Adult Patients with Mild to Moderate COVID-19.
Kim, Yeon-Sook; Jeon, Seng-Ho; Kim, Junghee; Koh, Jong Hoon; Ra, Seung Won; Kim, Ji Won; Kim, Yeonjae; Kim, Choon Kwan; Shin, Yun Chul; Kang, Beo Deul; Kang, Seung Ji; Park, Chul Hee; Lee, Boyoung; Lee, Ji Yeon; Lee, Chung Hoon; Choi, Jae-Phil; Kim, Jin Yong; Yu, Shi Nae; Peck, Kyong Ran; Kim, Sung-Han; Heo, Jung Yeon; Kim, Hyun Ah; Park, Hyun-Jin; Choi, Jongwon; Han, Jumi; Kim, JooHyun; Kim, Hyoung Jun; Han, Se Hee; Yoon, Aeri; Park, MiHee; Park, SuJung; Kim, YuKyung; Jung, Minji; Oh, Myoung-Don.
Afiliação
  • Kim YS; Department of Internal Medicine, Chungnam National University School of Medicine, Daejeon, South Korea.
  • Jeon SH; Daewoong Pharmaceutical Co., Ltd., Seoul, South Korea.
  • Kim J; Department of Neurosurgery, Seoul Medical Center, Seoul, South Korea.
  • Koh JH; Department of Internal Medicine, Seonam Hospital, Seoul, South Korea.
  • Ra SW; Department of Internal Medicine, Ulsan University Hospital, University of Ulsan College of Medicine, Ulsan, South Korea.
  • Kim JW; Department of Internal Medicine, SMG-SNU Boramae Medical Center, Seoul National University College of Medicine, Seoul, South Korea.
  • Kim Y; Division of Infectious Diseases, Department of Internal Medicine, National Medical Center, Seoul, South Korea.
  • Kim CK; Department of Internal Medicine, Veterans Health Service Medical Center, Seoul, South Korea.
  • Shin YC; Department of Anesthesiology and Pain Medicine, Gyeonggi Provincial Medical Center Pocheon Hospital, Pocheon, South Korea.
  • Kang BD; Department of Internal Medicine, Gyeonggi Provincial Medical Center Ansung Hospital, Ansung, South Korea.
  • Kang SJ; Department of Internal Medicine, Chonmam National University Medical School, Gwangju, South Korea.
  • Park CH; Department of Internal Medicine, Gyeonggi Provincial Medical Center Icheon Hospital, Icheon, South Korea.
  • Lee B; Department of Internal Medicine, Gyeonggi Provincial Medical Center Uljeongbu Hospital, Uljeongbu, South Korea.
  • Lee JY; Department of Internal Medicine, Keimyung University Dongsan Hospital, Daegu, South Korea.
  • Lee CH; Department of Obstetrics and Gynecology, Gyeonggi Provincial Medical Center Suwon Hospital, Suwon, South Korea.
  • Choi JP; Department of Internal Medicine, Seoul Medical Center, Seoul, South Korea.
  • Kim JY; Department of Internal Medicine, Incheon Medical Center, Incheon, South Korea.
  • Yu SN; Department of Internal Medicine, Soonchunhyang University Cheonan Hospital, Cheonan, South Korea.
  • Peck KR; Division of Infectious Diseases, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea.
  • Kim SH; Department of Internal Medicine, Asan Medical Centergrid.413967.e, Seoul, South Korea.
  • Heo JY; Department of Infectious Diseases, Ajou University School of Medicine, Suwon, South Korea.
  • Kim HA; Department of Medicine, Division of Infectious Diseases, Keimyung University Dongsan Hospital, Keimyung University School of Medicine, Daegu, South Korea.
  • Park HJ; Clinical Development Center, Daewoong Pharmaceutical Co., Ltd., Seoul, South Korea.
  • Choi J; Clinical Development Center, Daewoong Pharmaceutical Co., Ltd., Seoul, South Korea.
  • Han J; Clinical Development Center, Daewoong Pharmaceutical Co., Ltd., Seoul, South Korea.
  • Kim J; Clinical Development Center, Daewoong Pharmaceutical Co., Ltd., Seoul, South Korea.
  • Kim HJ; Clinical Development Center, Daewoong Pharmaceutical Co., Ltd., Seoul, South Korea.
  • Han SH; Clinical Development Center, Daewoong Pharmaceutical Co., Ltd., Seoul, South Korea.
  • Yoon A; Clinical Development Center, Daewoong Pharmaceutical Co., Ltd., Seoul, South Korea.
  • Park M; Clinical Development Center, Daewoong Pharmaceutical Co., Ltd., Seoul, South Korea.
  • Park S; Clinical Development Center, Daewoong Pharmaceutical Co., Ltd., Seoul, South Korea.
  • Kim Y; Clinical Development Center, Daewoong Pharmaceutical Co., Ltd., Seoul, South Korea.
  • Jung M; Clinical Development Center, Daewoong Pharmaceutical Co., Ltd., Seoul, South Korea.
  • Oh MD; Department of Internal Medicine, Seoul National University College of Medicine, Seoul, South Korea.
Antimicrob Agents Chemother ; 67(1): e0045222, 2023 01 24.
Article em En | MEDLINE | ID: mdl-36515544

Texto completo: 1 Base de dados: MEDLINE Assunto principal: COVID-19 Idioma: En Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Coréia do Sul

Texto completo: 1 Base de dados: MEDLINE Assunto principal: COVID-19 Idioma: En Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Coréia do Sul